Showing results (381-390 of 488) with videos related to
Sort By:
Pageof 49
Lancet (London, England)|August 28, 2015
Integrated molecular analysis to investigate the role of microRNAs in pancreatic tumour growth and progressionAdam E Frampton, Leandro Castellano, Teresa Colombo, et al.Breast (Edinburgh, Scotland)|February 3, 2012
A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapyAndrew Fong, Jesmin Shafiq, Christobel Saunders, et al.Integrative Cancer Therapies|January 3, 2026
The Efficacy and Safety of Nutritional Supplements for Cancer Supportive Care: An Umbrella Review and Hierarchical Evidence SynthesisSarah Benna-Doyle, Suzanne Grant, Alison Maunder, et al.EMBO Reports|February 17, 2016
miR-515-5p controls cancer cell migration through MARK4 regulationOlivier E Pardo, Leandro Castellano, Catriona E Munro, et al.Cancer|April 8, 2014
Patient-derived xenografts for individualized care in advanced sarcomaJustin Stebbing, Keren Paz, Gary K Schwartz, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 14, 2024
Kinome-Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in GlioblastomaViviana Vella, Angeliki Ditsiou, Anna Chalari, et al.Frontiers in Oncology|July 1, 2021
EGFR-Mutated Squamous Cell Lung Cancer and Its Association With OutcomesRui Jin, Ling Peng, Jiawei Shou, et al.Oncotarget|April 19, 2016
Prospective validation of microRNA signatures for detecting pancreatic malignant transformation in endoscopic-ultrasound guided fine-needle aspiration biopsiesAdam E Frampton, Jonathan Krell, Mireia Mato Prado, et al.The Lancet. Oncology|June 9, 2017
CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trialJustin Stebbing, Yauheni Baranau, Valeriy Baryash, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panelEwan K A Millar, Peter H Graham, Sandra A O'Toole, et al.Pageof 49